Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer G. BonadonnaP. ValagussaU. Veronesi Research Synthesis Pages: 95 - 115
Impact of flow cytometry on predicting recurrence and survival in breast cancer patients William L McGuireJohn S MeyerTimothy E Kute Viewpoints Pages: 117 - 128
Polyamines and estrogen control of growth of the NMU-induced rat mammary tumor Andrea ManniCarol WrightMichel Pontari Report Pages: 129 - 136
Heterogeneity of estrogen binding sites in breast cancer: Morphologic demonstration and relationship to endocrine response Louis P PertschukKaren B EisenbergJoseph G Feldman Report Pages: 137 - 147
Estradiol and progesterone receptors in breast cancer: Prognostic value after relapse J BonneterreD HornerA Demaille Report Pages: 149 - 154
The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas Roland HähnelElla Twaddle Report Pages: 155 - 163
Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer Charlotte SumidaHenri MagdelenatJorge Raul Pasqualini Report Pages: 165 - 169
Seasonal variation in breast cancer detection: Correlation with tumour progesterone receptor status B. H. MasonI. M. HoldawayS. J. Skinner Report Pages: 171 - 176
Short term high density systemic therapy for metastatic breast cancer DC TormeyJ C KlineP P Carbone Report Pages: 177 - 188
Mitomycin-C plus metronidazole in advanced carcinoma of the breast David J StewartJean A MarounAlfred F Crook Report Pages: 189 - 194
Weight gain during adjuvant chemotherapy for breast cancer K Z HeasmanH J SutherlandNF Boyd Report Pages: 195 - 200
Family history and bilateral primary breast cancer M A ChaudaryR R MillisJ L Hayward Report Pages: 201 - 205
International workshop on monoclonal antibodies and breast cancer Jerry A PetersonRoberto L Ceriani Meeting report Pages: 207 - 214